Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians Clearside Biomedical NASDAQCLSD

ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. CLSD, a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced the appointment of Arshad M. Khanani, M.D., M.A, F.A.S.R.S and Lejla Vajzovic, M.D., F.A.S.R.S to its Scientific Advisory Board (SAB). Clearside’s SAB is comprised of industry leading retinal physicians who provide medical and scientific expertise and input on the Company’s research and development programs. The SAB members are: Thomas A. Ciulla, M.D., M.B.A., Chair David S. Boyer, M.D. David M. Brown, M.D. Arshad M. Khanani, M.D., M.A.,…